[Leprosy].
Ishii
Norihisa
N
Department of Bioregulation, Leprosy Research Center, National Institute of Infectious Diseases (NIID).
Sasaki
Shin
S
D003622:Dapsone / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage; D007918:Leprosy / Q000145:classification / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D009166:Mycobacterium leprae / Q000276:immunology; D011379:Prognosis; D012293:Rifampin / Q000008:administration & dosage; D014944:World Health Organization
D007917:Leprostatic Agents; D003622:Dapsone; D012293:Rifampin